Related Experiment Video
Updated: Dec 23, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus
Zhenguo Zhai1,2,3, Chenghong Li4, Yaolong Chen5
1Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
Insights
This expert consensus provides guidance on managing venous thromboembolism (VTE) in COVID-19 patients. It offers practical recommendations for prophylaxis and treatment, addressing challenges in antithrombotic therapy for coronavirus disease 2019.
Area of Science:
- Internal Medicine
- Infectious Diseases
- Hematology
Background:
- Coronavirus disease 2019 (COVID-19) has led to a global pandemic.
- Severe coagulation abnormalities are observed in nearly 20% of COVID-19 patients, particularly in severe and critical cases.
- Venous thromboembolism (VTE) is frequently reported in COVID-19, complicating patient management.
Purpose of the Study:
- To develop an evidence and opinion-based consensus on VTE prophylaxis and management in COVID-19.
- To provide practical recommendations for clinicians treating COVID-19 patients with VTE.
- To address the complexities of antithrombotic therapy in the context of COVID-19-associated coagulation disorders.
Main Methods:
- A comprehensive literature review was conducted.
- Frontline practical experience from experts and physicians in China and Europe was incorporated.
- An expert consensus statement was developed based on gathered evidence and opinions.
Main Results:
- The consensus offers detailed recommendations for VTE prophylaxis and management in COVID-19.
- Guidance is provided on selecting thromboprophylactic measures based on disease severity and bleeding risk.
- Recommendations cover the choice of anticoagulant therapies for COVID-19-associated VTE.
Conclusions:
- This expert consensus statement provides crucial guidance for clinicians managing VTE in COVID-19 patients.
- The recommendations aim to assist healthcare professionals worldwide in addressing the challenges of COVID-19-associated VTE.
- The consensus offers specific suggestions to improve patient care and outcomes related to VTE in the context of the pandemic.
Abstract:
Coronavirus disease 2019 (COVID-19) has caused a global pandemic in just a few months, causing millions infected. Nearly 20% of COVID-19 patients present severe coagulation abnormalities, which may occur in almost all of the severe and critical ill COVID-19 cases. Concomitant venous thromboembolism (VTE), a potential cause of unexplained deaths, has been frequently reported in COVID-19 cases, but its management is still challenging due to the complexity between antithrombotic therapy and coagulation disorders. Based on frontline practical experience and comprehensive literature review, here a panel of experts and physicians from China and Europe developed an evidence and opinion-based consensus on the prophylaxis and management of VTE associated with COVID-19. This statement aims for clinicians treating COVID-19 and provides practical recommendations in detailed situations, for example, how to choose thromboprophylactic measures for patients with diverse severity of disease and bleeding risk, or which kind of anticoagulant should be prescribed. With limited experience on COVID19-associated VTE, this expert consensus statement should be helpful for clinicians worldwide with specific suggestions.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

